The effects of apoptosis stimulation were confirmed to occur only in cells expressing GLP-1R in a gain-of-function experiment ( 4.2 Hepatic metabolic modulation effects by GLP-1RAs GLP-1RAs replicate the action of the incretin hormone GLP-1, which primarily involves boosting insulin release, reducing glucagon secretion, and increasing feelings of fullness, ultimately leading to improved glycemic control and supporting weight management (Xu et al., 2024)
Weeks 13 through 16: increase to 10mg The 10mg dose represents a significant jump in therapeutic effect
The maintenance doses range from 5 mg to 15 mg weekly, depending on response and tolerability
Growth Hormone Secretagogues Growth hormone secretagogues (GHS) are a class of compounds that have become a hot topic in research regarding their role in stimulating the release of growth hormone (GH) from the pituitary gland
Additionally, research highlighting the cardiovascular benefits of GLP-1 receptor agonists encouraged broader acceptance among physicians and patients, reinforcing North Americas growing demand for advanced diabetes therapies
FDA calls for investigation Based on reports from women who have experienced miscarriage or other pregnancy issues while taking these medications, the FDA is now requiring Novo Nordisk to conduct an investigation